Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2024. Fourth Quarter 2024 Total revenue increased ...

Investigation Discovery dove into the case of Nicholas Rossi, legal name Nicholas Alahverdian, in The Curious Case of … The ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...

There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...

Since the first time-traveling adventure in the TARDIS in 1963, Doctor Who earned its place as one of the all-time greats of ...

On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

The Orphan Winfrey Network’s hit dating series ‘Ready to Love’ is on it’s way to the city of brotherly love, Philadelphia. The show features Black men and women in their 30s and 40s looking for love.

Goodman memorializes de la Rocque de Roberval and her remarkable valor through masterful writing, reminding the 21st century ...

Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...